Advanced Pharmacotherapy In Cardiovascular Disease Management Practice Tests

Question 1

Which of the following best describes the initiating event in the pathophysiology of an acute coronary syndrome?

Accepted Answer

Rupture of an atherosclerotic plaque's fibrous cap exposing thrombogenic contents

Answer

Chronic narrowing of the coronary artery due to stable plaque growth

Answer

Vasospasm of the coronary artery without underlying atherosclerosis

Answer

Systemic hypertension leading to left ventricular hypertrophy

Question 2

Which P2Y12 inhibitor is contraindicated in patients with a history of prior stroke or transient ischemic attack (TIA)?

Accepted Answer

Prasugrel

Answer

Clopidogrel

Answer

Ticagrelor

Answer

Cangrelor

Question 3

Heparin-Induced Thrombocytopenia (HIT) is primarily a bleeding disorder caused by the inhibition of clotting factors.

Accepted Answer

False

Answer

True

Question 4

What is the primary mechanism of action of aspirin in the setting of ACS?

Accepted Answer

Irreversible inhibition of COX-1, preventing thromboxane A2 production

Answer

Reversible inhibition of the P2Y12 receptor

Answer

Direct inhibition of Factor Xa

Answer

Activation of plasminogen to plasmin

Question 5

Which of the following are considered absolute contraindications to the administration of thrombolytic therapy in a STEMI patient?

Answer

History of intracranial hemorrhage

Answer

Active internal bleeding

Answer

History of hypertension

Answer

Age over 65 years

Question 6

What is the recommended door-to-balloon time goal for primary percutaneous coronary intervention (PCI) in STEMI patients?

Accepted Answer

90 minutes

Question 7

Which medication class is specifically used to actively dissolve established fibrin clots?

Accepted Answer

Thrombolytics

Answer

Antiplatelets

Answer

Anticoagulants

Answer

Statins

Question 8

Which anticoagulant is the preferred choice for patients with a history of Heparin-Induced Thrombocytopenia (HIT) requiring anticoagulation during PCI?

Accepted Answer

Bivalirudin

Answer

Unfractionated Heparin

Answer

Enoxaparin

Answer

Warfarin

Question 9

According to current clinical guidelines for a patient with established ASCVD, what is the recommended LDL-C target level?

Accepted Answer

B. <70 mg/dL

Answer

A. <100 mg/dL

Answer

C. <55 mg/dL

Answer

D. <130 mg/dL

Question 10

Which of the following medication regimens is classified as high-intensity statin therapy?

Accepted Answer

C. Atorvastatin 40-80 mg

Answer

A. Simvastatin 10-20 mg

Answer

B. Pravastatin 10-20 mg

Answer

D. Fluvastatin 20-40 mg

Question 11

PCSK9 inhibitors function by preventing the degradation of hepatic LDL receptors, thereby increasing the clearance of LDL-C from the blood.

Accepted Answer

True

Answer

False

Question 12

Which class of medication is primarily indicated for the treatment of severe hypertriglyceridemia to prevent the complication of pancreatitis?

Accepted Answer

A. Fibrates

Answer

B. PCSK9 inhibitors

Answer

C. Ezetimibe

Answer

D. Bempedoic acid

Question 13

What is the primary mechanism of action of Ezetimibe in the management of dyslipidemia?

Accepted Answer

Inhibition of cholesterol absorption in the small intestine

Question 14

Why is interrupting the neurohormonal cycle in heart failure considered superior to solely increasing myocardial contractility?

Accepted Answer

It prevents maladaptive cardiac remodeling such as fibrosis and chamber dilation.

Answer

It immediately restores the Frank-Starling curve to normal.

Answer

It eliminates the need for loop diuretics in all patients.

Answer

It directly increases the heart's oxygen supply.

Question 15

A patient presents with structural heart disease but currently reports no symptoms of heart failure. According to the ACC/AHA staging system, which stage is this patient in?

Accepted Answer

Stage B

Answer

Stage A

Answer

Stage C

Answer

Stage D

Question 16

Which of the following medications are considered part of the 'Fantastic Four' GDMT for HFrEF that have been shown to reduce mortality?

Answer

ARNI

Answer

Evidence-based beta-blocker

Answer

Loop diuretics

Answer

MRA

Answer

SGLT2 inhibitor

Answer

Digoxin

Question 17

Loop diuretics are essential for managing fluid overload in heart failure, but they do not provide a mortality benefit.

Accepted Answer

True

Answer

False

Question 18

Which of the following is the most appropriate next step for a patient diagnosed with resistant hypertension who is already taking three antihypertensive medications, including a diuretic?

Accepted Answer

Add Spironolactone

Answer

Increase the dose of the current ACE inhibitor

Answer

Add a beta-blocker

Answer

Switch to a central alpha-2 agonist

Question 19

What is the primary clinical risk associated with the abrupt withdrawal of central alpha-2 agonists like Clonidine?

Accepted Answer

Rebound hypertension

Question 20

A patient taking Minoxidil for severe resistant hypertension develops excessive hair growth. Which side effect is this?

Accepted Answer

Hypertrichosis

Answer

Drug-induced lupus

Answer

Reflex tachycardia

Answer

Orthostatic hypotension

Advanced Pharmacotherapy In Cardiovascular Disease Management Practice Tests

Practice Tests

Advanced Pharmacotherapy in Cardiovascular Disease Management

Generate Advanced Pharmacotherapy In Cardiovascular Disease Management practice tests with AI